← dashboard
BIIB BIOGEN INC.
// CIK 0000875045 | IPO le 1991-09-17 — il y a 35a | Cap $27.62B
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate (Tecfidera), diroximel fumarate (Vumerity), interferon beta-1a (AVONEX), peginterferon beta-1a (Plegridy), and natalizumab (Tysabri), all for the treatment of multiple sclerosis ; nusinersen (Spinraza) for the treatment of spinal muscular atrophy ; omaveloxolone (Skyclarys) for the treatment of Friedreich's ataxia ; tofersen (Qalsody) for the treatment of ALS; and dimethyl fum…
INSIDERS
insider filings tx volume top score
Viehbacher Christopher 3 10 $2.81M 39
Singhal Priya 5 17 $1.92M 39
Izzar Rachid 3 11 $710k 39
ALEXANDER SUSAN H 2 10 $705k 39
Murphy Nicole 2 11 $672k 64
Gregory Ginger 2 10 $521k 39
Keeney Adam 4 13 $458k 39
Kramer Robin 2 10 $310k 39
Grogan Jane 3 10 $251k 39
Minor Lloyd 3 4 $240k 49
DORSA CAROLINE 2 2 $152k 62
Godbout Sean 4 16 $83k 39
Pangalos Menelas N 2 4 54
LANGER SUSAN 2 2 50
Patolawala Monish D 2 2 51
Mantas Jesus B 2 2 49
Parini Michael 1 1 27
Freire Maria C 2 2 50
Rowinsky Eric K 2 2 47
HAWKINS WILLIAM A 2 2 49
SHERWIN STEPHEN A 2 2 49
RECENT TRANSACTIONS
score date ▼ insider role type qty price value SEC
27
CLUSTER
2026-09-01 Parini Michael Chief Legal Officer A Attribution 7,405
34
CLUSTER
2026-08-04 Minor Lloyd S Vente marché 593 $200.96 $119k
28
CLUSTER
2026-08-03 Minor Lloyd S Vente marché 593 $203.34 $121k
29
CLUSTER
2026-06-09 HAWKINS WILLIAM A A Attribution 1,505
29
CLUSTER
2026-06-09 SHERWIN STEPHEN A A Attribution 1,505
29
CLUSTER
2026-06-09 Rowinsky Eric K A Attribution 1,505
29
CLUSTER
2026-06-09 Mantas Jesus B A Attribution 1,505
31
CLUSTER
2026-06-09 LANGER SUSAN A Attribution 1,505
31
CLUSTER
2026-06-09 Patolawala Monish D A Attribution 1,505
0
2026-06-09 Pangalos Menelas N M Exercice option 2,370
32
CLUSTER
2026-06-09 Minor Lloyd A Attribution 1,505
31
CLUSTER
2026-06-09 Freire Maria C A Attribution 2,005
32
CLUSTER
2026-06-09 Pangalos Menelas N A Attribution 1,505
0
2026-06-09 Pangalos Menelas N M Exercice option 2,370
0
2026-05-01 Keeney Adam Head of Corporate Development M Exercice option 939
0
2026-05-01 Keeney Adam Head of Corporate Development F Retenue fiscale 455 $187.06 $85k
0
2026-05-01 Keeney Adam Head of Corporate Development M Exercice option 939
0
2026-04-01 Godbout Sean Chief Accounting Officer M Exercice option 181
0
2026-04-01 Godbout Sean Chief Accounting Officer F Retenue fiscale 54 $183.78 $10k
0
2026-04-01 Godbout Sean Chief Accounting Officer M Exercice option 181
39
CLUSTER
2026-02-13 ALEXANDER SUSAN H EVP Chief Legal Officer A Attribution 8,450
39
CLUSTER
2026-02-13 Godbout Sean Chief Accounting Officer A Attribution 1,800
39
CLUSTER
2026-02-13 Gregory Ginger EVP, Human Resources A Attribution 8,025
39
CLUSTER
2026-02-13 Grogan Jane Head of Research A Attribution 8,450
39
CLUSTER
2026-02-13 Izzar Rachid Head of Global Product Strat. A Attribution 7,390
39
CLUSTER
2026-02-13 Keeney Adam Head of Corporate Development A Attribution 8,025
39
CLUSTER
2026-02-13 Kramer Robin Chief Financial Officer A Attribution 8,450
39
CLUSTER
2026-02-13 Singhal Priya Head of Development A Attribution 10,560
39
CLUSTER
2026-02-13 Viehbacher Christopher President and CEO A Attribution 38,015
36
CLUSTER
2026-02-13 Murphy Nicole Head of Pharm Ops and Tech A Attribution 10,560
64
CLUSTER
2026-02-12 Murphy Nicole Head of Pharm Ops and Tech P Achat marché 3 $195.03 $585
33
2026-02-09 Singhal Priya Head of Development S Vente marché 2,660 $199.83 $532k
0
2026-02-06 ALEXANDER SUSAN H EVP Chief Legal Officer M Exercice option 2,190
0
2026-02-06 Godbout Sean Chief Accounting Officer M Exercice option 257
0
2026-02-06 Gregory Ginger EVP, Human Resources M Exercice option 1,635
0
2026-02-06 Grogan Jane Head of Research M Exercice option 1,385
0
2026-02-06 Izzar Rachid Head of Global Product Strat. M Exercice option 2,044
0
2026-02-06 Keeney Adam Head of Corporate Development M Exercice option 1,802
0
2026-02-06 Kramer Robin Chief Financial Officer M Exercice option 789
0
2026-02-06 Murphy Nicole Head of Pharm Ops and Tech M Exercice option 2,102
0
2026-02-06 Singhal Priya Head of Development M Exercice option 2,217
0
2026-02-06 Viehbacher Christopher President and CEO M Exercice option 9,008
0
2026-02-06 ALEXANDER SUSAN H EVP Chief Legal Officer F Retenue fiscale 1,059 $201.18 $213k
0
2026-02-06 Godbout Sean Chief Accounting Officer F Retenue fiscale 76 $201.18 $15k
0
2026-02-06 Gregory Ginger EVP, Human Resources F Retenue fiscale 791 $201.18 $159k
0
2026-02-06 Grogan Jane Head of Research F Retenue fiscale 407 $201.18 $82k
0
2026-02-06 Izzar Rachid Head of Global Product Strat. F Retenue fiscale 805 $201.18 $162k
0
2026-02-06 Keeney Adam Head of Corporate Development F Retenue fiscale 589 $201.18 $118k
0
2026-02-06 Kramer Robin Chief Financial Officer F Retenue fiscale 273 $201.18 $55k
0
2026-02-06 Murphy Nicole Head of Pharm Ops and Tech F Retenue fiscale 1,017 $201.18 $205k
0
2026-02-06 Singhal Priya Head of Development F Retenue fiscale 1,056 $201.18 $212k
0
2026-02-06 Viehbacher Christopher President and CEO F Retenue fiscale 4,356 $201.18 $876k
0
2026-02-06 ALEXANDER SUSAN H EVP Chief Legal Officer M Exercice option 1,940
0
2026-02-06 Godbout Sean Chief Accounting Officer M Exercice option 305
0
2026-02-06 Gregory Ginger EVP, Human Resources M Exercice option 1,802
0
2026-02-06 Grogan Jane Head of Research M Exercice option 1,873
0
2026-02-06 Izzar Rachid Head of Global Product Strat. M Exercice option 1,802
0
2026-02-06 Keeney Adam Head of Corporate Development M Exercice option 3,278
0
2026-02-06 Kramer Robin Chief Financial Officer M Exercice option 703
0
2026-02-06 Murphy Nicole Head of Pharm Ops and Tech M Exercice option 1,940
0
2026-02-06 Singhal Priya Head of Development M Exercice option 4,683
0
2026-02-06 Viehbacher Christopher President and CEO M Exercice option 15,453
0
2026-02-06 ALEXANDER SUSAN H EVP Chief Legal Officer F Retenue fiscale 931 $201.18 $187k
0
2026-02-06 Godbout Sean Chief Accounting Officer F Retenue fiscale 103 $201.18 $21k
0
2026-02-06 Gregory Ginger EVP, Human Resources F Retenue fiscale 666 $201.18 $134k
0
2026-02-06 Grogan Jane Head of Research F Retenue fiscale 584 $201.18 $117k
0
2026-02-06 Izzar Rachid Head of Global Product Strat. F Retenue fiscale 458 $201.18 $92k
0
2026-02-06 Keeney Adam Head of Corporate Development F Retenue fiscale 994 $201.18 $200k
0
2026-02-06 Kramer Robin Chief Financial Officer F Retenue fiscale 207 $201.18 $42k
0
2026-02-06 Murphy Nicole Head of Pharm Ops and Tech F Retenue fiscale 914 $201.18 $184k
0
2026-02-06 Singhal Priya Head of Development F Retenue fiscale 1,412 $201.18 $284k
0
2026-02-06 Viehbacher Christopher President and CEO F Retenue fiscale 6,624 $201.18 $1.33M
0
2026-02-06 ALEXANDER SUSAN H EVP Chief Legal Officer M Exercice option 4,916
0
2026-02-06 Godbout Sean Chief Accounting Officer M Exercice option 517
0
2026-02-06 Gregory Ginger EVP, Human Resources M Exercice option 3,746
0
2026-02-06 Grogan Jane Head of Research M Exercice option 1,385
0
2026-02-06 Izzar Rachid Head of Global Product Strat. M Exercice option 3,043
0
2026-02-06 Keeney Adam Head of Corporate Development M Exercice option 1,802
0
2026-02-06 Kramer Robin Chief Financial Officer M Exercice option 3,511
0
2026-02-06 Murphy Nicole Head of Pharm Ops and Tech M Exercice option 4,683
0
2026-02-06 Viehbacher Christopher President and CEO M Exercice option 9,008
0
2026-02-06 ALEXANDER SUSAN H EVP Chief Legal Officer F Retenue fiscale 1,514 $201.18 $305k
0
2026-02-06 Godbout Sean Chief Accounting Officer F Retenue fiscale 180 $201.18 $36k
0
2026-02-06 Gregory Ginger EVP, Human Resources F Retenue fiscale 1,132 $201.18 $228k
0
2026-02-06 Grogan Jane Head of Research M Exercice option 1,873
0
2026-02-06 Izzar Rachid Head of Global Product Strat. F Retenue fiscale 775 $201.18 $156k
0
2026-02-06 Keeney Adam Head of Corporate Development M Exercice option 3,278
0
2026-02-06 Kramer Robin Chief Financial Officer F Retenue fiscale 1,063 $201.18 $214k
0
2026-02-06 Murphy Nicole Head of Pharm Ops and Tech F Retenue fiscale 1,408 $201.18 $283k
0
2026-02-06 Singhal Priya Head of Development M Exercice option 2,217
0
2026-02-06 Viehbacher Christopher President and CEO M Exercice option 15,453
0
2026-02-06 ALEXANDER SUSAN H EVP Chief Legal Officer M Exercice option 2,190
0
2026-02-06 Godbout Sean Chief Accounting Officer M Exercice option 257
0
2026-02-06 Gregory Ginger EVP, Human Resources M Exercice option 1,635
0
2026-02-06 Izzar Rachid Head of Global Product Strat. M Exercice option 2,044
0
2026-02-06 Kramer Robin Chief Financial Officer M Exercice option 789
0
2026-02-06 Murphy Nicole Head of Pharm Ops and Tech M Exercice option 2,102
0
2026-02-06 Singhal Priya Head of Development M Exercice option 4,683
0
2026-02-06 ALEXANDER SUSAN H EVP Chief Legal Officer M Exercice option 1,940
0
2026-02-06 Godbout Sean Chief Accounting Officer M Exercice option 305
0
2026-02-06 Gregory Ginger EVP, Human Resources M Exercice option 1,802
0
2026-02-06 Izzar Rachid Head of Global Product Strat. M Exercice option 1,802
0
2026-02-06 Kramer Robin Chief Financial Officer M Exercice option 703
0
2026-02-06 Murphy Nicole Head of Pharm Ops and Tech M Exercice option 1,940
0
2026-02-06 ALEXANDER SUSAN H EVP Chief Legal Officer M Exercice option 4,916
0
2026-02-06 Godbout Sean Chief Accounting Officer M Exercice option 517
0
2026-02-06 Gregory Ginger EVP, Human Resources M Exercice option 3,746
0
2026-02-06 Izzar Rachid Head of Global Product Strat. M Exercice option 3,043
0
2026-02-06 Kramer Robin Chief Financial Officer M Exercice option 3,511
0
2026-02-06 Murphy Nicole Head of Pharm Ops and Tech M Exercice option 4,683
29
2026-02-02 Singhal Priya Head of Development S Vente marché 748 $179.30 $134k
0
2026-01-30 Singhal Priya Head of Development M Exercice option 1,829
0
2026-01-30 Singhal Priya Head of Development F Retenue fiscale 582 $179.89 $105k
0
2026-01-30 Singhal Priya Head of Development M Exercice option 1,829
0
2025-12-01 Viehbacher Christopher President and CEO M Exercice option 7,040
0
2025-12-01 Viehbacher Christopher President and CEO F Retenue fiscale 3,404 $177.78 $605k
0
2025-12-01 Viehbacher Christopher President and CEO M Exercice option 7,040
0
2025-10-31 Grogan Jane Head of Research M Exercice option 695
0
2025-10-31 Grogan Jane Head of Research F Retenue fiscale 337 $154.27 $52k
0
2025-10-31 Grogan Jane Head of Research M Exercice option 695
0
2025-10-02 Godbout Sean Chief Accounting Officer M Exercice option 26
0
2025-10-02 Godbout Sean Chief Accounting Officer F Retenue fiscale 8 $155.25 $1k
0
2025-10-02 Godbout Sean Chief Accounting Officer M Exercice option 26
35
CLUSTER
2025-09-02 Singhal Priya Head of Development S Vente marché 517 $133.55 $69k
0
2025-08-29 Singhal Priya Head of Development M Exercice option 1,669
0
2025-08-29 Singhal Priya Head of Development F Retenue fiscale 807 $132.22 $107k
0
2025-08-29 Singhal Priya Head of Development M Exercice option 1,669
31
CLUSTER
2025-07-08 Izzar Rachid Head of Global Product Strat. S Vente marché 2,223 $135.00 $300k
44
CLUSTER
2025-06-17 DORSA CAROLINE A Attribution 3,160
50
CLUSTER
2025-06-17 LANGER SUSAN A Attribution 2,370
49
CLUSTER
2025-06-17 SHERWIN STEPHEN A A Attribution 2,370
47
CLUSTER
2025-06-17 Rowinsky Eric K A Attribution 2,370
50
CLUSTER
2025-06-17 Freire Maria C A Attribution 2,370
49
CLUSTER
2025-06-17 HAWKINS WILLIAM A A Attribution 2,370
49
CLUSTER
2025-06-17 Mantas Jesus B A Attribution 2,370
51
CLUSTER
2025-06-17 Patolawala Monish D A Attribution 2,370
49
CLUSTER
2025-06-17 Minor Lloyd A Attribution 2,370
54
CLUSTER
2025-06-17 Pangalos Menelas N A Attribution 2,370
32
CLUSTER
2025-05-19 Singhal Priya Head of Development S Vente marché 3,806 $126.25 $481k
62
CLUSTER
2025-05-02 DORSA CAROLINE P Achat marché 1,235 $122.72 $152k
0
2025-05-01 Keeney Adam Head of Corporate Development M Exercice option 938
0
2025-05-01 Keeney Adam Head of Corporate Development F Retenue fiscale 454 $120.93 $55k
0
2025-05-01 Keeney Adam Head of Corporate Development M Exercice option 938